#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Subarachnoid haemorrhage Ewing's sarcoma Corneal neovascularisation Usher's syndrome Adenocarcinoma pancreas Pulmonary tuberculosis Neuronal ceroid lipofuscinosis Juvenile chronic myelomonocytic leukaemia Meningococcal immunisation Rhabdoid tumour Neutropenia Chronic myeloid leukaemia (in remission) Acute respiratory distress syndrome Toxic epidermal necrolysis Partial lipodystrophy More trials…

    Learn about Rare Diseases

    Glomerulonephritis rapidly progressive – Treatment Marginal zone lymphoma – Life with Disease Hyperoxaluria – Trials in Disease Pelizaeus-Merzbacher disease – Life with Disease Haemophilia A with anti factor VIII – Trials in Disease Alport’s syndrome – Trials in Disease Breast angiosarcoma – Treatment Behcet’s syndrome – Life with Disease Cerebral arteriovenous malformation haemorrhagic – Basic Information Splenic marginal zone lymphoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    TEV-53408 Brimonidine Tartrate Dapansutrile SODIUM DIHYDROGEN PHOSPHATE Ethanol, Anhydrous Abc-24F-116 Alemtuzumab TRAZODONE HYDROCHLORIDE Bicalutamide Lenalidomide Benserazide Hydrochloride Filgrastim Pralatrexate Siplizumab Abc-23A-116 Sumatriptan Succinate Ixazomib Citrate Human Fibrinogen Finerenone Crofelemer More therapies…

    Learn about Your Condition

    Breast cancer recurrent Fungal infection Skin wrinkling Nephrotic syndrome Acute coronary syndrome Mantle cell lymphoma recurrent Post procedural infection Crohn's disease Breast cancer stage I Invasive breast carcinoma Pleural mesothelioma malignant Arteriosclerosis Aortic aneurysm Gaucher's disease type III Undifferentiated sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study comparing RP2 with nivolumab versus ipilimumab with nivolumab in adults with metastatic uveal melanoma not previously treated with immune checkpoint inhibitors

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Uveal melanoma
    Investigated Drugs:
    • RP2
    • Ipilimumab
    • Nivolumab
    France Germany Italy Poland Spain

  • A Study Testing the Safety of CD19-Targeted CAR T-Cell Therapy in Children and Young Adults with Relapsed or Refractory B-Cell Cancers

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia recurrent
    • B-cell lymphoma recurrent
    • B-cell lymphoma refractory
    Investigated Drugs:
    • MB-HUCART19.1
    The Netherlands

  • Study of Fecal Microbiota Transplantation Compared to Sham Treatment for Patients with Primary Sclerosing Cholangitis

    Not yet recruiting

    4 1
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    • Placebo
    France

  • A study to test if atorvastatin can prevent eye disease in patients newly diagnosed with Graves’ disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    • Graves’ disease
    Investigated Drugs:
    • Atorvastatin
    Sweden

  • A study testing dapagliflozin and SC0062 together compared to SC0062 alone in adults with type 1 diabetes and chronic kidney disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    • Chronic kidney disease
    Investigated Drugs:
    • SC0062
    • Dapagliflozin
    Denmark Finland The Netherlands

  • A Study Using Indocyanine Green Fluorescence Imaging to Help Surgeons Better Identify Tumor Edges During Cancer Surgery in Patients with Solid Tumors

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Gastrointestinal carcinoma
    • Genitourinary tract neoplasm
    • Head and neck cancer
    Investigated Drugs:
    • Indocyanine Green
    The Netherlands
Previous Page
1 … 747 748 749 750 751 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!